Wendy Blosser - 04 Mar 2022 Form 3 Insider Report for Accustem Sciences Inc. (ACUT)

Role: Chief Executive Officer, Director
Signature: /s/ Wendy Blosser
Issuer symbol: ACUT
Transactions as of: 04 Mar 2022
Net transactions value: $0
Form type: 3
Filing time: 27 May 2022, 10:37:22 UTC
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ACUT	Common Stock						2,000	04 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ACUT	Options (right to buy)							04 Mar 2022	Common Stock	490,000	$2.13	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	49,000 of the options vest on January 25, 2023, 2024 and 2025 and 98,000 vest on January 25, 2026. 122,500 options vest upon the closing of a single equity raise netting not less than $30m for the Company; and 122,500 options vest upon the opening of a commercial CLIA lab in the U.S. no later than the fourth quarter 2023.